Summary. The phospho-oligosaccharide extracted from rat liver and supposed to act as the insulin second messenger inhibits glucose-stimulated insulin release. In the present study, this phospho-oligosaccharide was found not to affect D-[U-14C]glucose oxidation and 45Ca net uptake, but to inhibit insulin release evoked by either D-glucose or 2-ketoisocaproate in isolated rat islets. The relative extent of the latter inhibition was unaffected by either the concentration of D-glucose or the presence of dibutyryl-cyclic AMP, forskolin or glucagon in the incubation medium. At variance with the inhibitory effect of clonidine, that of the phospho-oligosaccharide was resistant to both blockade of c~2-adrenergic receptors or pre-treatment with the toxin of BordeteIla pertussis. It is speculated, therefore, that such a phospho-oligosaccharide might interfere with a distal event in the insulin secretory sequence.
In several target cells, insulin provokes, by a phospholipase C mechanism, the generation from a glycolipid of a phospho-oligosaccharide (POS), which is thought to act as the insulin "second messenger" [1] [2] [3] [4] . It was recently reported that pancreatic islet cells contain a comparable glycolipid and that POS, extracted from rat liver, inhibits insulin secretion [5] . The present study deals with the possible mode of action of POS upon insulin release from isolated rat islets.
Materials and methods
POS was prepared from rat liver by a method described elsewhere [61. Briefly, a liver membrane fraction was extracted with acidified chloroform/methanol and the insulin-sensitive glycophospholipid first isolated by successive thin layer chromatographies on silica gel G and then treated with the phospholipase C of S. aureus. The H20-soluble POS generated in this manner amounts to about 20 (range 8 to 40) nmol per rat liver. One unit of POS is here arbitrarily defined as the material extracted from the liver of one rat. Highly purified porcine glucagon and idazoxan were kindly provided by Novo Research Institute (Bagsvaerd, Denmark) and Reekitt and Colman (Kingstonupon-Hull, U.K.), respectively.
All experiments were conducted in isolated islets removed from fed albino rats [7] . In one series of experiments, six rats (182 _+ 4 g body weight) were injected intraperitoneally with the toxin of Bordetella pertussis (2.8 gg per rat; [8] ) and killed 48 to 72 h later. In these animals, the daily gain in body weight did not exceed 0.7 +_ t.2 g (n = 6).
The oxidation of D-[U-14C]-glucose [9] , net uptake of 45Ca [10] and release of insulin [7] by the islets were all measured over 90 min incubation by methods described in the cited references. Neither POS, nor glucagon interfered with the immunoassay of insulin.
In control experiments, no inhibition of glucose-stimulated insulin release was observed when fractions, other than those containing the insulin-sensitive glycophospholipid, were derived from the second chromatography of the liver extract and treated with the phosphatidylinositol-specific phospholipase C from Bacillus cereus [6] . Likewise, glucose-stimulated insulin release was not significantly affected by either material obtained when the liver lipid fraction had not been exposed to the specific phospholipase C or blank material prepared in the absence of liver lipid but the presence of the specific phospholipase C ( Table 1 ). The inhibitory, action of POS upon insulin release was suppressed after its inactivation by nitrous acid, followed by chromatography on a Dowex AG-1-X8 column [6] .
Statistical analysis
All results are presented as the mean _+ SEM together with the number of individual observations (n). The statistical significance of differences between mean values was assessed by the use of Student's t-test.
Results

Effect of POS upon D-glucose oxidation
Whether at low (2.8 mmol/l) or high (16.7 mmol/1) concentration of D-glucose, POS (0.04 to 0.21 U/ml) failed to affect significantly (p>0.1) the oxidation of D-[U-14C]glucose by isolated rat islets ( Table 2) .
Effect of POS upon 45Ca net uptake
A rise in D-glucose concentration from 2.8 to 16.7 mm01/1 provoked a two-to three-fold increase in 45Ca net uptake by the islets (p < 0.001). At both hexose concentrations, POS (0.04 to 0.21 U/ml) failed to affect significantly (p> 0.6) the net uptake of 45Ca (Table 3) . (Fig.l, left panel) . The relative extent of the inhibitory action of POS was little affected by either the length of incubation (60 to 90 min; data not shown) or, as documented in Table 4 , by the concentration of D-glucose used to stimulate insulin release. The close-to-basal insulin output recorded at low concentrations of the hexose (2.8 or 5.6 mmol/1) was also decreased by POS (p< 0.05). POS inhibited insulin release evoked, in the absence of D-glucose, by 2-ketoisocaproate (10 mmol/1). It should be underlined that, at the concentrations of POS used in most of the present experiments (0.13 to 0.21 U/ml), the relative extent of the inhibitory action of POS upon insulin release did not e:~ceed 30 to 40% of the control value ( Table 4) .
Effect of POS upon insulin release attributable to cyclic AMP
Since POS may mediate, in selected target cells, the inhibitory action of insulin upon agonist-stimulated adeny!ate cyclase activity, we have examined the effect of POS upon insulin release evoked by secretagogues affecting cyclic AMP generation in the islets (Table 5) . These experiments were all performed in the presence of 16.7 mmol/l o-glucose, because all the agents tested (db-cAMP, forskolin and glucagon) fail to affect insulin release in the absence of exogenous nutrient, but markedly augment glucose-stimulated insulin output [11, 12] . Exogenous db-cAMP indeed significantly augmented glucose-stimulated insulin release, both in the absence 
Comparison between the secretory responses to POS and elonidine
The inhibitory action of POS upon insulin release differed from that of clonidine by its resistance to the antagonistic effect of the r blocking agent idazoxan (Table 6 ). Indeed, whereas clonidine exerted a much more severe inhibition of insulin release than POS (p< 0.001), the adrenergic agent failed to affect significantly insulin release in the presence of idazoxan (p>0.2). In the presence of POS, however, idazoxan failed to affect significantly insulin output (p > 0.1). As a consequence of these contrasting effects, the release of insulin was lower in the presence of POS than clonidine (p<0.01) when the islets were exposed to both D-glucose and idazoxan.
Comparable results were obtained when the islets were removed from rats injected with the toxin of Bordetella pertussis and killed 2 to 3 days later. In such a case, the release of insulin evoked by D-glucose averaged 447.0+ 22.5 IxU/90 min per islet (n= 20), which is higher (p < 0.005) than the mean value recorded, within the same series of experiments, in islets removed from control rats (339.9 +20.7 ~U/90 min per islet; n=20). Clonidine failed to significantly decrease insulin release in the islets removed from the toxin-treated rats (p> 0.05). However, in the latter islets, POS still caused inhibition of insulin release (p< 0.005). The relative extent of such an inhibition was comparable (p> 0.7) to that evoked by POS in islets removed from control rats and exposed to idazoxan and not significantly different (p> 0.05) from that evoked by POS in control islets not exposed to idazoxan.
Discussion
In several tissues exposed to insulin, POS appears to be generated at the outer surface of the cell and released in the extracellular medium and, then, to act upon target cells [13] [14] [15] . The exposure of intact cells to POS would seem appropriate, therefore, to investigate the mode of action of this presumed insulin second messenger.
The present results confirm that POS inhibits glucose-stimulated insulin release [5] . In this series of experiments, the relative extent of such an inhibitory action did not exceed 30 to 40% of the control secretory rate. It is conceivable, however, that higher concentrations of POS may exert a more pronounced inhibition of insulin release [5] .
It seems unlikely that POS specifically interferes with the process of glucose identification by the B cell, as presumably linked to the catabolism of the hexose [16] . Indeed, POS failed to affect D-[UJ4C]glucose oxidation by the islets, and inhibited insulin release evoked by the nutrient secretagogue 2-ketoisocaproate.
A primary action of POS upon those cationic events participating in the process of nutrient-stimulated insulin release cannot be ruled out. The finding that POS failed to affect both basal and glucose-stimulated 45Ca net uptake argues, however, against such a view.
The data collected in islets exposed to db-cAMP, forskolin and glucagon further suggest that POS does not interfere preferentially with either the generation of cyclic AMP or the functional response to this nucleotide. Indeed, the relative extent of the inhibitory action of POS upon glucose-induced insulin release was similar in the absence and presence of db-cAMP, forskolin or glucagon.
The inhibitory action of POS upon insulin release differed vastly from that of clonidine, by its resistance to the antagonistic effect of either a selective a2-adrenergic blocking agent (idazoxan) or pre-treatment with the toxin of Bordetella pertussis. These findings argue against the hypothesis that the action of POS is mediated'at the intervention of c~2-adrenergic receptors and/or the GTP-binding protein Ni previously identified in islet cells [8] . Incidentally, we also observed that clonidine fails to affect the efflux of radioactivity from islets pre-incubated with D-[1-t4C]galactose or D-[1-14C]glucosamine (unpublished observation) in order to label the insulin-sensitive glycolipid [5] . This suggests that the generation of POS is not stimulated by the occupancy of a2-adrenergic receptors.
Taken as a whole, these findings suggest that POS may act upon insulin release at a rather distal site in the secretory sequence, e.g. at the level of those biochemical reactions involved in the activation of the effector system responsible for the translocation of secretory granules and their access to the exocytotic site. For instance, the participation of specific protein-kinases in these motile events could conceivably represent a site of action for POS [6, 17, 18] .
Whatever its intimate mode of action, the finding that POS inhibits insulin release evoked by distinct secretagogues could be relevant to the response of the B cell to either insulin itself or somatomedin-C. It was indeed recently proposed that purified B cells are devoid of high-affinity insulin receptors but are equipped with IGF-1 receptors through which insulin, in high concentrations, could conceivably affect B cell growth or function [19] [20] . We have so far been unable, however, to detect any obvious effect of insulin, anti-insulin serum or somatomedin-C upon insulin release from isolated rat islets [21] [22] [23] . Moreover, there is yet no evidence that the occupancy of IGF-1 receptors affects POS production.
In conclusion, POS inhibits insulin release apparently by interfering with a late: event in the secretory sequence, at a site distal to those metabolic and cationic events involved in the process of nutrient-stimulated insulin secretion. Further work is obviously required, to progress in our understanding of both the mode of action of POS upon insulin release and the identity of those first messengers which might stimulate its generation in islet cells.
